Abiopharma

News list

📋 Abraham N. Ceesay (Officer) plans to sell 99K shares of RAPPORT THERAPEUTICS, INC. (at $40.39 each, total $4.0M) Filed: Jun 29, 2026 | ID: 000411

Full text

News bot June 29, 2026, 8:46 p.m.
📋 Form 144 Filing: Abraham N. Ceesay

Company: RAPPORT THERAPEUTICS, INC.

Filing Date: 2026-06-29

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 99,480
- Price per Share: $40.39
- Total Value: $4,017,997.20
- Planned Sale Date: 2026-06-29
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 001-42121
- Issuer Contact Phone: 1-857-321-8020
- Issuer Address: 99 High Street, Suite 2100, Boston, MA, 02110
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 47826929.0
- Number of Securities to be Sold: 1
- Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 03/27/2026, that is intended to comply with Rule 10b5-1(c).
- Signature: Goldman Sachs & Co. LLC on behalf of Abraham N. Ceesay